Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial

Pathologically elevated immune activation and inflammation contribute to HIV disease progression and immunodeficiency, potentially mediated by elevated levels of prostaglandin E(2), which suppress HIV-specific T cell responses. We have previously shown that a high dose of the cyclooxygenase-2 inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Prebensen, Christian, Trøseid, Marius, Ueland, Thor, Dahm, Anders, Sandset, Per Morten, Aaberge, Ingeborg, Waalen, Kristian, Dyrhol-Riise, Anne Ma, Taskén, Kjetil, Kvale, Dag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413033/
https://www.ncbi.nlm.nih.gov/pubmed/28464042
http://dx.doi.org/10.1371/journal.pone.0176527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413033/
https://www.ncbi.nlm.nih.gov/pubmed/28464042
http://dx.doi.org/10.1371/journal.pone.0176527

Ejemplares similares